Eads & Heald Wealth Management Lowers Stake in Bristol-Myers Squibb (NYSE:BMY)

Eads & Heald Wealth Management decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,632 shares of the biopharmaceutical company’s stock after selling 511 shares during the quarter. Eads & Heald Wealth Management’s […]

Leave a Reply

Your email address will not be published.

Previous post Amgen Inc. (NASDAQ:AMGN) Holdings Lowered by Whittier Trust Co.
Next post Updated 2024 Tesla Model 3 Becomes Available in USA with a $38,990 Starting Price